Abstract:BACKGROUND:RNA splicing defects are emerging molecular hallmarks of cancer. The gene encoding splicing factor RNA binding motif protein 10 (RBM10) has been found frequently mutated in various types of cancer, particularly lung adenocarcinoma (LUAD), but how RBM10 affects cancer pathogenesis remains to be determined. Moreover, the functional roles and clinical significance of RBM10 mutation-associated splicing events in LUAD are largely unknown.METHODS:RBM10 mutations and their functional impacts were examined in LUAD patients from a Chinese patient cohort and The Cancer Genome Atlas (TCGA). Alternative splicing (AS) changes induced by RBM10 mutations in LUAD were identified by RNA sequencing and correlated with patient survival. Functions of RBM10 and the splice variants of eukaryotic translation initiation factor 4H containing or lacking exon 5 (EIF4H-L and EIF4H-S respectively) in LUAD development and progression were examined by cellular phenotypic assays and xenograft tumour formation.FINDINGS:RBM10 mutations in LUAD generally lead to loss-of-function and cause extensive alterations in splicing events that can serve as prognostic predictors. RBM10 suppresses LUADprogression largely by regulating alternative splicing of EIF4H exon 5. Loss of RBM10 in LUAD enhances the expression of EIF4H-L in LUAD. EIF4H-L, but not EIF4H-S, is critical for LUAD cell proliferation, survival and tumourigenesis.INTERPRETATION:Our study demonstrates a new molecular mechanism underlying RBM10 suppressive functions in lung cancer and the therapeutic value of RBM10-regulated AS events, providing important mechanistic and translational insights into splicing defects in cancer.

Integrative Analysis Revealed the Molecular Mechanism Underlying RBM10-mediated Splicing Regulation

Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.

Crystal structure and functional characterization of the human RBM25 PWI domain and its flanking basic region.

Functional Analysis Reveals That RBM10 Mutations Contribute to Lung Adenocarcinoma Pathogenesis by Deregulating Splicing.

Rbm3 deficiency leads to transcriptome-wide splicing alterations

An RNA architectural locus control region involved in Dscam mutually exclusive splicing

Targeting Dysregulated Splicing Factors in Cancer: Lessons Learned from RBM10 Deficiency.

1 Cross-talk between PRMT 1-mediated methylation and ubiquitylation on RBM 15 controls RNA splicing 1

Transcriptome analysis of alternative splicing events regulated by SRSF10 reveals position-dependent splicing modulation

Cross-talk Between PRMT1-mediated Methylation and Ubiquitylation on RBM15 Controls RNA Splicing

Capture RIC-seq reveals positional rules of PTBP1-associated RNA loops in splicing regulation

An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression

RNA Binding Motif Protein 10 Suppresses Lung Cancer Progression by Controlling Alternative Splicing of Eukaryotic Translation Initiation Factor 4H

RBM-5 Modulates U2AF Large Subunit-Dependent Alternative Splicing Inc. Elegans

In-silico modeling and interpretation of RBP binding disentangle m6A-RBP interaction

RBM20 phosphorylation on serine/arginine domain is crucial to regulate pre-mRNA splicing and protein shuttling in the heart

Genome-wide Analysis of PTB-RNA Interactions Reveals a Strategy Used by the General Splicing Repressor to Modulate Exon Inclusion or Skipping

RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.

Integrated Analysis of a Compendium of RNA-Seq Datasets for Splicing Factors.

Large-scale evaluation of the ability of RNA-binding proteins to activate exon inclusion